Rallybio Corp (RLYB)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Rallybio Corp-Aktie (RLYB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.00% 0.212	0.212	0.212	0.002	0.299
Operating Expenses	30.50% 7.137	10.27	9.882	11.65	12.37
Benefits Costs and Expenses	264.15% -15.80	9.628	9.064	10.62	11.13
Costs And Expenses	264.15% -15.80	9.628	9.064	10.62	11.13
Depreciation and Amortization	34.62% 0.035	0.026	0.028	0.03	0.032
Operating Income/Loss	31.14% -6.925	-10.06	-9.67	-11.61	-12.07
Nonoperating Income/Loss	3,479% 22.94	0.641	0.818	0.994	1.237
Income/Loss Before Equity Method Investments	270.09% 16.02	-9.416	-8.852	-10.61	-10.83
Income/Loss From Equity Method Investments	100.00% -	-0.287	-0.587	-0.43	-0.637
Income/Loss From Continuing Operations Before Tax	270.09% 16.02	-9.416	-8.852	-10.61	-10.83
Income/Loss From Continuing Operations After Tax	270.09% 16.02	-9.416	-8.852	-10.61	-10.83
Net Income/Loss	265.06% 16.02	-9.703	-9.439	-11.04	-11.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.48% 45.06	44.84	44.77	0.3746	44.59
Diluted Average Shares	0.48% 45.06	44.84	44.77	0.3746	44.59
Basic Earnings Per Share	263.64% 0.36	-0.22	-0.21	-0.25	-0.26
Diluted Earnings Per Share	263.64% 0.36	-0.22	-0.21	-0.25	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%